OKTA Gears Up to Report Q1 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2278835/okta-gears-up-to-report-q1-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2278835
May 24, 2024 - OKTA's first-quarter fiscal 2025 results are expected to reflect the continued adoption of Workforce and Customer Identity solutions.
0
Icon PLC (ICLR) Up 6.6% Since Last Earnings Report: Can It Continue?
https://www.zacks.com/stock/news/2278765/icon-plc-iclr-up-6-6-since-last-earnings-report-can-it-continue?cid=CS-ZC-FT-realtime_blog-2278765
May 24, 2024 - Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
IBM (IBM) Up 1% Since Last Earnings Report: Can It Continue?
https://www.zacks.com/stock/news/2278764/ibm-ibm-up-1-since-last-earnings-report-can-it-continue?cid=CS-ZC-FT-realtime_blog-2278764
May 24, 2024 - IBM (IBM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
CACI International (CACI) Up 5.9% Since Last Earnings Report: Can It Continue?
https://www.zacks.com/stock/news/2278780/caci-international-caci-up-5-9-since-last-earnings-report-can-it-continue?cid=CS-ZC-FT-realtime_blog-2278780
May 24, 2024 - CACI International (CACI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
Core Laboratories (CLB) Up 6.2% Since Last Earnings Report: Can It Continue?
https://www.zacks.com/stock/news/2278782/core-laboratories-clb-up-6-2-since-last-earnings-report-can-it-continue?cid=CS-ZC-FT-realtime_blog-2278782
May 24, 2024 - Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
https://www.zacks.com/stock/news/2278882/iovance-iova-up-5-on-updated-data-from-melanoma-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2278882
May 24, 2024 - Iovance (IOVA) shares updated data from a mid-stage study, which showed that treatment with its combination therapy achieved an objective response rate of 65% in frontline advanced melanoma.
0
Shoe Carnival (SCVL) Q1 Earnings Beat Estimates, Sales Up Y/Y
https://www.zacks.com/stock/news/2278666/shoe-carnival-scvl-q1-earnings-beat-estimates-sales-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2278666
May 24, 2024 - Shoe Carnival's (SCVL) Q1 results reflect significant revenue growth in the sandal category, gross margin expansion, improved cost management and enhanced pricing power.
0
Deep Fishing For Bargains: 2 Preferred Stocks Up To 9% Yield
https://seekingalpha.com/article/4695274-deep-fishing-for-bargains-2-preferred-stocks-up-to-9-percent-yield?source=feed
May 24, 2024 - Our fixed-income allocation features high-yield, attractively discounted preferred securities. Check out these 2 quality preferred stocks.
0
Billionaire Investor Dan Loeb Just Loaded Up on These 2 "Magnificent Seven" Artificial Intelligence (AI) Stocks
https://www.fool.com/investing/2024/05/24/billionaire-investor-dan-loeb-just-loaded-up-on/?source=iedfolrf0000001
May 24, 2024 - Dan Loeb made some interesting moves during the first quarter, buying up shares in two members of the Magnificent Seven.
0
Justice Department sues to break up Live Nation, parent of Ticketmaster
https://www.cnbc.com/2024/05/23/justice-department-sues-live-nation-ticketmaster.html
May 23, 2024 - The lawsuit follows a DOJ probe bolstered by fan complaints following a botched rollout for tickets to Taylor Swift's Eras Tour.
0